search
Back to results

Evaluation of Lotrafilcon A Lenses Over a Three Month Period

Primary Purpose

Myopia

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Lotrafilcon A contact lens
Sponsored by
CIBA VISION
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Myopia

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • On examination, have ocular findings considered to be "normal" and which would not prevent a subject from safely wearing contact lenses.
  • Be willing and able to follow instructions and meet the schedule of follow-up visits as defined in the informed consent.
  • Be able to wear the study lenses in the available powers.
  • Currently wear contact lenses for a minimum of 5 days a week, and at least 8 hours a day.
  • Other protocol inclusion/exclusion criteria may apply.

Exclusion Criteria:

  • Eye injury or surgery within twelve weeks immediately prior to enrollment for this trial.
  • Pre-existing ocular irritation that would preclude contact lens fitting.
  • Currently enrolled in an ophthalmic clinical trial.
  • Evidence of systemic or ocular abnormality, infection or disease likely to affect successful wear of contact lenses or use of their accessory solutions.
  • Any use of medications for which contact lens wear would be contraindicated, in the opinion of the investigator.
  • History of corneal refractive surgery.
  • Other protocol inclusion/exclusion criteria may apply.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    Lotrafilcon A

    Arm Description

    Outcomes

    Primary Outcome Measures

    Comfort After Insertion
    Comfort after insertion of contact lens (30 seconds to 1 minute), as interpreted by the subject and reported by the subject as a single, retrospective evaluation of 3-month's wear time. Comfort after insertion was measured on a 10-point scale, with 1 being poor and 10 being excellent.

    Secondary Outcome Measures

    Full Information

    First Posted
    July 1, 2009
    Last Updated
    June 26, 2012
    Sponsor
    CIBA VISION
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00931307
    Brief Title
    Evaluation of Lotrafilcon A Lenses Over a Three Month Period
    Official Title
    Evaluation of Lotrafilcon A Lenses Over a Three Month Period
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2010
    Overall Recruitment Status
    Completed
    Study Start Date
    May 2009 (undefined)
    Primary Completion Date
    September 2009 (Actual)
    Study Completion Date
    September 2009 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    CIBA VISION

    4. Oversight

    5. Study Description

    Brief Summary
    The purpose of this trial is to assess the performance of a Lotrafilcon A contact lens over a 3-month period.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Myopia

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    22 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Lotrafilcon A
    Arm Type
    Experimental
    Intervention Type
    Device
    Intervention Name(s)
    Lotrafilcon A contact lens
    Intervention Description
    Silicone hydrogel, spherical, soft contact lens
    Primary Outcome Measure Information:
    Title
    Comfort After Insertion
    Description
    Comfort after insertion of contact lens (30 seconds to 1 minute), as interpreted by the subject and reported by the subject as a single, retrospective evaluation of 3-month's wear time. Comfort after insertion was measured on a 10-point scale, with 1 being poor and 10 being excellent.
    Time Frame
    3 months

    10. Eligibility

    Sex
    All
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: On examination, have ocular findings considered to be "normal" and which would not prevent a subject from safely wearing contact lenses. Be willing and able to follow instructions and meet the schedule of follow-up visits as defined in the informed consent. Be able to wear the study lenses in the available powers. Currently wear contact lenses for a minimum of 5 days a week, and at least 8 hours a day. Other protocol inclusion/exclusion criteria may apply. Exclusion Criteria: Eye injury or surgery within twelve weeks immediately prior to enrollment for this trial. Pre-existing ocular irritation that would preclude contact lens fitting. Currently enrolled in an ophthalmic clinical trial. Evidence of systemic or ocular abnormality, infection or disease likely to affect successful wear of contact lenses or use of their accessory solutions. Any use of medications for which contact lens wear would be contraindicated, in the opinion of the investigator. History of corneal refractive surgery. Other protocol inclusion/exclusion criteria may apply.

    12. IPD Sharing Statement

    Learn more about this trial

    Evaluation of Lotrafilcon A Lenses Over a Three Month Period

    We'll reach out to this number within 24 hrs